Table of Contents

2019-2024 Global Subcutaneous Immunotherapy Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Subcutaneous Immunotherapy Market Size 2014-2024
  • 2.1.2 Subcutaneous Immunotherapy Market Size CAGR by Region
• 2.2 Subcutaneous Immunotherapy Segment by Type
  • 2.2.1 Asthma
  • 2.2.2 Allergic Rhinitis
  • 2.2.3 Venom Allergy
  • 2.2.4 Food Allergy
• 2.3 Subcutaneous Immunotherapy Market Size by Type
  • 2.3.1 Global Subcutaneous Immunotherapy Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (2014-2019)
• 2.4 Subcutaneous Immunotherapy Segment by Application
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Online Pharmacies
  • 2.4.3 Retail Pharmacies
• 2.5 Subcutaneous Immunotherapy Market Size by Application
  • 2.5.1 Global Subcutaneous Immunotherapy Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Subcutaneous Immunotherapy Market Size Growth Rate by Application (2014-2019)

3 Global Subcutaneous Immunotherapy by Players

• 3.1 Global Subcutaneous Immunotherapy Market Size Market Share by Players
  • 3.1.1 Global Subcutaneous Immunotherapy Market Size by Players (2017-2019)
  • 3.1.2 Global Subcutaneous Immunotherapy Market Size Market Share by Players (2017-2019)
• 3.2 Global Subcutaneous Immunotherapy Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Subcutaneous Immunotherapy by Regions

• 4.1 Subcutaneous Immunotherapy Market Size by Regions
• 4.2 Americas Subcutaneous Immunotherapy Market Size Growth
• 4.3 APAC Subcutaneous Immunotherapy Market Size Growth
• 4.4 Europe Subcutaneous Immunotherapy Market Size Growth
• 4.5 Middle East & Africa Subcutaneous Immunotherapy Market Size Growth

5 Americas

• 5.1 Americas Subcutaneous Immunotherapy Market Size by Countries
• 5.2 Americas Subcutaneous Immunotherapy Market Size by Type
• 5.3 Americas Subcutaneous Immunotherapy Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Subcutaneous Immunotherapy Market Size by Countries
• 6.2 APAC Subcutaneous Immunotherapy Market Size by Type
• 6.3 APAC Subcutaneous Immunotherapy Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Subcutaneous Immunotherapy by Countries
• 7.2 Europe Subcutaneous Immunotherapy Market Size by Type
• 7.3 Europe Subcutaneous Immunotherapy Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Subcutaneous Immunotherapy by Countries
• 8.2 Middle East & Africa Subcutaneous Immunotherapy Market Size by Type
• 8.3 Middle East & Africa Subcutaneous Immunotherapy Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Subcutaneous Immunotherapy Market Forecast

• 10.1 Global Subcutaneous Immunotherapy Market Size Forecast (2019-2024)
• 10.2 Global Subcutaneous Immunotherapy Forecast by Regions
  • 10.2.1 Global Subcutaneous Immunotherapy Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Subcutaneous Immunotherapy Forecast by Type
• 10.8 Global Subcutaneous Immunotherapy Forecast by Application

11 Key Players Analysis

• 11.1 Anergis
  • 11.1.1 Company Details
  • 11.1.2 Subcutaneous Immunotherapy Product Offered
  • 11.1.3 Anergis Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Anergis News
• 11.2 HAL Allergy Group
  • 11.2.1 Company Details
  • 11.2.2 Subcutaneous Immunotherapy Product Offered
  • 11.2.3 HAL Allergy Group Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 HAL Allergy Group News
• 11.3 Merck
  • 11.3.1 Company Details
  • 11.3.2 Subcutaneous Immunotherapy Product Offered
  • 11.3.3 Merck Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Merck News
• 11.4 Allergy Therapeutics
  • 11.4.1 Company Details
  • 11.4.2 Subcutaneous Immunotherapy Product Offered
  • 11.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Allergy Therapeutics News
• 11.5 ALK-Abello
  • 11.5.1 Company Details
  • 11.5.2 Subcutaneous Immunotherapy Product Offered
  • 11.5.3 ALK-Abello Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 ALK-Abello News
• 11.6 Stallergenes Greer
  • 11.6.1 Company Details
  • 11.6.2 Subcutaneous Immunotherapy Product Offered
  • 11.6.3 Stallergenes Greer Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Stallergenes Greer News
• 11.7 Laboratorios LETI
  • 11.7.1 Company Details
  • 11.7.2 Subcutaneous Immunotherapy Product Offered
  • 11.7.3 Laboratorios LETI Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Laboratorios LETI News

...

12 Research Findings and Conclusion

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.

According to this study, over the next five years the Subcutaneous Immunotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Subcutaneous Immunotherapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Subcutaneous Immunotherapy market by product type, application, key companies and key regions.

This study considers the Subcutaneous Immunotherapy value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Asthma
Allergic Rhinitis
Food Allergy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Subcutaneous Immunotherapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Subcutaneous Immunotherapy market by identifying its various subsegments.
Focuses on the key global Subcutaneous Immunotherapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Subcutaneous Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Subcutaneous Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.